| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1347323A Chemical compounds |
| 05/01/2002 | CN1347322A Chemical compounds |
| 05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
| 05/01/2002 | CN1347309A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1347308A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1346678A Weak epitope dominating system and therapeutic hepatitis B vaccine prepared with it |
| 05/01/2002 | CN1346674A Wanpi ointment |
| 05/01/2002 | CN1346660A Medicine for treating tonsillitis and its preparing process |
| 05/01/2002 | CN1346645A Snuff pill for treating TB and ulcer |
| 05/01/2002 | CN1346641A Freezed dried centipede |
| 05/01/2002 | CN1346634A Process for preparing miconazole nitrate ointment |
| 05/01/2002 | CN1346633A 利巴韦林脂质体制剂 Ribavirin liposomal formulation |
| 04/30/2002 | US6380391 Reacting difunctional alkanes containing halogen or aliphatic or aromataic sulfonyloxide reactive functional groups with 4-aminopyrimidine derivative in presence of water and organic solvent (alcohols, glycols, polyglycols, mono or diethers) |
| 04/30/2002 | US6380376 Purity polypeptides |
| 04/30/2002 | US6380359 Liposomes comprising peptide antigens derived from X protein of hepatitis B virus |
| 04/30/2002 | US6380245 For therapy of fungal infection disease |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380194 For treatment of subjects suffering from hiv infection |
| 04/30/2002 | US6380190 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thererof |
| 04/30/2002 | US6380189 2-amino benzoxazinones for the treatment of viral infections |
| 04/30/2002 | US6380181 Synthetic catechol derivatives, method for production and use thereof |
| 04/30/2002 | US6380170 Nucleic acid construct for the cell cycle regulated expression of structural genes |
| 04/30/2002 | US6380157 Administering medicament comprising papillomavirus l2 protein, or a therapeutically effective fragment thereof for therapy of papillomavirus infection |
| 04/30/2002 | US6380156 Having antiviral, antitumor, and immunosuppressive activities |
| 04/30/2002 | US6379931 Derived from spacer reagent 3-(4,4'-dimethoxytrityloxy)propane-1-((2-cyanoethyl)-(n,n-diisopropyl)) -phosphoramidite; use treating viral and rna-mediated diseases such as hiv |
| 04/30/2002 | US6379926 Polynucleotides encoding chemokine β-6 antagonists |
| 04/30/2002 | US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 04/30/2002 | US6379714 Pharmaceutical grade botanical drugs |
| 04/30/2002 | US6379707 Solid solution of amorphous pharmaceutically active agent, pharmaceutically acceptable hydrophobic vehicle, stabilizer, disintegrant; shelf life |
| 04/30/2002 | US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety |
| 04/30/2002 | US6379691 Supplying to tissues of vascular system |
| 04/30/2002 | US6379685 Acidic aqueous chlorite teat dip with improved emollient providing shelf life, sanitizing capacity and tissue protection |
| 04/30/2002 | US6379675 Immunological combination compositions and methods |
| 04/30/2002 | CA2230307C Aquatic animal treatment method and composition containing cajeput oil |
| 04/30/2002 | CA2200771C New silicated salicylic acid derivatives with desquamative properties |
| 04/30/2002 | CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 04/30/2002 | CA2176929C Vaccine against mumps containing a jeryl-lynn virus strain |
| 04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
| 04/30/2002 | CA2131761C Crystals of pyridonecarboxylic acid derivative |
| 04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 04/26/2002 | CA2324631A1 A substance or composition for the treatment of cancer |
| 04/25/2002 | WO2002033417A1 Assay for directly detecting a rs virus related biological cell in a body fluid sample |
| 04/25/2002 | WO2002033376A2 Polypeptides inhibiting hepatitis c virus internal ribosome entry site (ires), and method for screening said polypeptides |
| 04/25/2002 | WO2002033101A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033050A2 Methods and compositions for promoting the maturation of monocytes |
| 04/25/2002 | WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 04/25/2002 | WO2002032920A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/25/2002 | WO2002032919A2 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance |
| 04/25/2002 | WO2002032918A2 Ketolide antibacterials |
| 04/25/2002 | WO2002032917A1 Macrolides |
| 04/25/2002 | WO2002032916A2 Sixteen-membered macrolide compounds |
| 04/25/2002 | WO2002032915A1 Combinatorial libraries of monosaccharides |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032891A1 Flavan compounds, their preparation and their use in therapy |
| 04/25/2002 | WO2002032889A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use |
| 04/25/2002 | WO2002032879A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032873A1 Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections |
| 04/25/2002 | WO2002032461A2 Protein c or activated protein c-like molecules |
| 04/25/2002 | WO2002032453A1 Synthetic peptide hog cholera vaccine and method producing it |
| 04/25/2002 | WO2002032452A1 Composition for aids and method producing it |
| 04/25/2002 | WO2002032447A2 Cell damage inhibitor |
| 04/25/2002 | WO2002032444A1 Novel medicinal herbal composition for treating liver diseases and hiv |
| 04/25/2002 | WO2002032424A1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers |
| 04/25/2002 | WO2002032423A1 Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2002032414A2 Ribavirin-pegylated interferon alfa hcv combination therapy |
| 04/25/2002 | WO2002032404A2 Nanoparticles |
| 04/25/2002 | WO2002032397A2 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | WO2002032394A1 Delivery system and method of treating or preventing otitis media |
| 04/25/2002 | WO2002032378A2 Fusion cells and cytokine compositions for treatment of disease |
| 04/25/2002 | WO2002032233A2 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
| 04/25/2002 | WO2002022112A9 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 04/25/2002 | WO2002010137A3 Indazole derivatives as JNK inhibitors |
| 04/25/2002 | WO2002002128A3 Oral compositions comprising antimicrobial agents |
| 04/25/2002 | WO2001092340A3 Use of interleukin-4 antagonists and compositions thereof |
| 04/25/2002 | WO2001083740A3 Splice-region antisense composition and method |
| 04/25/2002 | WO2001075072A3 Production of TcR gamma delta T cells |
| 04/25/2002 | WO2001072831A3 Immunoregulator |
| 04/25/2002 | WO2001072782A3 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/25/2002 | WO2001070262A3 A method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of hiv envelope proteins |
| 04/25/2002 | WO2001070208A3 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
| 04/25/2002 | WO2001060847A3 avirulent, immunogenic flavivirus chimeras |
| 04/25/2002 | WO2001047533A3 INHIBITION OF GSK-3$g(b) |
| 04/25/2002 | WO2001042471A3 Polypeptides and polynucleotides encoding same |
| 04/25/2002 | WO2001041810A3 Nucleic acid delivery system |
| 04/25/2002 | WO2001029193A3 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 04/25/2002 | US20020049243 Pyrrolidine derivatives |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049220 Substituted azoles |
| 04/25/2002 | US20020049218 2-, 6, and 9-substituted purine derivatives, particularly 2(1-R hydroxymethylpropylamino)-6-benzylamino-9-isopropyl purine, used as drug and herbicide; inhibiting effect with respect to cyclin-dependent kinase proteins |
| 04/25/2002 | US20020049215 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 04/25/2002 | US20020049205 Pyrazole antimicrobial agents |
| 04/25/2002 | US20020049202 Administering halogenated amidino or oxyamidino compound to treat diseases caused by nitric oxide synthase |
| 04/25/2002 | US20020049201 Sulfonamide inhibitors of aspartyl protease |